-
Liproxstatin-1 as a Ferroptosis Assay Probe
2026-08-08
Liproxstatin-1 is a selective ferroptosis inhibitor that helps distinguish lipid-peroxidation-driven death from nonspecific oxidative injury. This article explains how to use it as a causal assay probe, including careful interpretation of emerging fungal ferroptosis data.
-
hiPSC Intestinal Organoids for Pharmacokinetic Studies
2026-08-07
Saito and colleagues developed a streamlined direct 3D culture strategy for generating expandable, cryopreservable intestinal organoids from human induced pluripotent stem cells. After conversion to 2D intestinal epithelial monolayers, the organoids produced mature intestinal cell types with measurable transporter and CYP3A metabolic activities, supporting more human-relevant pharmacokinetic studies.
-
Y-27632 Dihydrochloride: Selective ROCK Inhibitor for Cancer
2026-08-07
Y-27632 dihydrochloride is a highly selective ROCK inhibitor used to study cytoskeletal regulation, stem cell viability, and tumor invasion in cancer research models. Its potency and specificity make it a preferred tool for dissecting Rho/ROCK signaling. Recent evidence confirms its role in advanced 3D organoid systems.
-
p-Cresyl Sulfate: Protocols and Optimization for Endothelial
2026-08-06
p-Cresyl sulfate, a key biomarker for uremia-related cardiovascular risk, unlocks reproducible in vitro and in vivo workflows for endothelial dysfunction and vascular calcification studies. This guide delivers actionable protocol enhancements, troubleshooting strategies, and insights from recent breakthroughs to elevate chronic kidney disease and cardiovascular research.
-
Omeprazole (A2845): Protocols for Gastric Acid Secretion Res
2026-08-06
Omeprazole (SKU A2845) is a validated H+,K+-ATPase inhibitor designed for controlled studies of gastric acid secretion and antiulcer activity in laboratory models. Researchers should use this compound exclusively for preclinical workflows, not for diagnostic or clinical applications. Adherence to solubility, storage, and assay-specific handling is essential to maintain data integrity.
-
MitMAB: Precision Inhibition for Endocytosis and Trafficking
2026-08-05
MitMAB (N,N,N-trimethyltetradecan-1-aminium bromide) enables precise, reproducible inhibition of dynamin-mediated endocytosis in advanced organoid and vesicle uptake assays. Leveraging data-driven protocols and novel insights from recent stem cell-based intestinal models, researchers can dissect membrane trafficking with unprecedented control.
-
Bifendate (DDB): Optimizing Hepatoprotection and Lipid Metab
2026-08-05
Bifendate (DDB) stands apart as a hepatoprotection agent by targeting both autophagy and lipid metabolism—enabling precise modeling of liver injury and metabolic dysregulation. This workflow-driven guide translates bench evidence and reference innovations into actionable protocols, troubleshooting strategies, and comparative insights for advanced liver disease research.
-
Reliable Bacterial Viability: Live-Dead Bacterial Staining K
2026-08-04
This article explores real-world laboratory challenges in bacterial viability assays and demonstrates how the Live-Dead Bacterial Staining Kit (SKU K2239) from APExBIO delivers reproducible, dual-fluorescence solutions. Benchmarked against current literature and alternative methods, the guide offers scenario-driven protocols and evidence-based recommendations for microbiology researchers.
-
Magnetic Stimulation Downregulates GABRE to Reverse Schizoph
2026-08-04
This study demonstrates that targeted magnetic stimulation of the left prelimbic cortex in mice downregulates the GABAA receptor epsilon (GABRE) subunit, reversing schizophrenia-like behaviors and synaptic deficits. The findings reveal a novel molecular pathway for neuromodulation-based therapies and propose Gabre as a promising target for future schizophrenia interventions.
-
Sulfisomidine in Pertussis Therapy: Clinical Evidence and Im
2026-08-03
The reference study presents a focused clinical evaluation of sulfisomidine (sulfamethin) for treating pertussis, including cases complicated by bronchopneumonia in infants and young children. The findings highlight the drug’s rapid attainment of therapeutic blood levels, overall safety under monitored conditions, and potential value as an alternative to traditional antibiotics, providing a foundation for methodologically robust research on sulfonamide applications.
-
Phospho-Tau Ser356 in Alzheimer’s Disease: Insights from NUA
2026-08-03
Taylor et al. (2023) identify tau phosphorylation at serine 356 (p-tau Ser356) as a Braak stage-dependent marker of Alzheimer’s pathology, with the NUAK1 kinase driving its accumulation. Their work demonstrates that selective pharmacological inhibition of NUAK reduces p-tau Ser356 in human brain tissue, highlighting a new mechanistic target for AD intervention.
-
AS1842856 Foxo1 Inhibitor: Precision Tool for Metabolic Path
2026-08-02
AS1842856 Foxo1 Inhibitor offers researchers unparalleled specificity for dissecting gluconeogenesis, autophagy, and stem cell activation pathways. Its potent activity and reliable performance make it a go-to reagent for metabolic disease and bone research workflows.
-
Liproxstatin-1: Ferroptosis Inhibition for Translational Bre
2026-08-01
Explore how Liproxstatin-1 is redefining ferroptosis research through mechanistic insights, robust validation, and strategic guidance for translational models—spanning from cell protection to antifungal innovation.
-
Dextrose (D-glucose) in Tumor Metabolism and Cell Assays
2026-07-31
Dextrose (D-glucose) from APExBIO empowers researchers with high solubility, purity, and batch consistency, optimizing studies in tumor immunometabolism and cell viability. This guide translates recent mechanistic insights into hands-on experimental workflows, troubleshooting tips, and protocol enhancements.
-
Mdivi-1: Selective DRP1 Inhibitor for Mitochondrial Dynamics
2026-07-31
Mdivi-1, a potent and selective DRP1 inhibitor, transforms mitochondrial dynamics research by enabling precise control over fission events and apoptosis pathways. New evidence from microbiome-based metabolomics underscores its relevance in complex disease models, while robust workflow guidance ensures reproducible results across cell and animal studies.